VA2CS vs. Seegnal

VA2CS functions without the requirement for wearable devices or any form of physical interaction, enabling it to effectively observe and evaluate a range of behaviors in a given environment, including instances of falling, fainting, nighttime activity, and behavioral changes, while also allowing for visual enhancement if necessary. By combining an optical sensor with sophisticated software, VA2CS can detect various occurrences of falls or loss of consciousness with precision. This groundbreaking system marks a notable leap forward, outpacing current technologies available in the market. Although the initial images captured might seem indistinct, they still convey essential details about an individual's positioning on the ground. Additionally, designated personnel can opt to improve the image's clarity when needed, facilitating accurate evaluations of the circumstances. This feature not only bolsters safety but also instills assurance for caregivers and family members, ensuring that they can respond effectively to emergencies. The ability to monitor without direct contact adds a layer of comfort, making it an invaluable asset in caregiving environments.

An intuitive real-time user interface created for use at the point of care significantly improves the prevention of Drug-Related Problems (DRPs) tailored to individual patients. DRPs rank as the fourth leading cause of mortality in the United States, resulting in around 150,000 deaths annually and comprising 6-10% of all hospital admissions. Moreover, patients who are prescribed five or more medications face over a 20% likelihood of experiencing serious DRPs, which in turn contribute to billions of dollars in avoidable healthcare expenses. Each month, nearly 4.5 million individuals in the U.S. visit emergency rooms due to complications arising from DRPs. The platform features the most extensive data integration available, offering 50% more unique information and the ability to synchronize data from multiple sources. By leveraging AI and machine learning, it delivers real-time insights customized to each patient, incorporating factors such as lab results, estimated glomerular filtration rate (eGFR), genetic profiles, dietary habits, and usage of over-the-counter drugs. With a remarkable accuracy rate of 98% for both specificity and sensitivity, it significantly reduces alert fatigue by generating only 6% of the alerts typically issued by conventional systems. Additionally, the patented visualization technology employed at the point of care facilitates the swift detection, prioritization, and resolution of issues within a rapid timeframe of just 5 to 10 seconds, ensuring that patient care is both timely and effective. This cutting-edge methodology not only reduces the risks linked to DRPs but also promotes overall healthcare efficiency, ultimately leading to improved patient outcomes and satisfaction.